Dedicated to Professor Guo-Qiang Lin on the occasion of his 70th birthdayOptically active b,b-diarylpropionic acids are a class of important building blocks for the asymmetric synthesis of chiral diarylmethine compounds, [1] which are structural moieties that are found in many pharmaceuticals and bioactive compounds, including the therapeutically important molecules tolterodine, [1a-b] sertraline, [1c] indatraline, [1d] and natural products, such as cherylline.[1e]Thus far, methods for the asymmetric synthesis of chiral b,b-diarylpropionic acids often involve a multistep sequence and/or stoichiometric transformation using chiral auxiliaries, [2] only a few examples of catalytic asymmetric methods, including Rh I -or Cu II -catalyzed reduction of b,b-diaryl unsaturated acrylates [3,4] or nitriles [5] using either polymethylhydrosiloxanes or diethoxymethylsilane as the reductants, and Rh I -catalyzed 1,4-addition of organoboron reagents to arylidene Meldrums acids, [6] have been reported to provide the corresponding b,b-diaryl propanoates or propanenitriles with good to high enantioselectivities. In terms of atom economy and environmental concerns, asymmetric hydrogenation of b,b-diarylacrylates with molecular H 2 is more advantageous. In this respect, Ir I -or Rh I -catalyzed asymmetric hydrogenation of trisubstituted olefins for the formation of diarylmethine stereogenic centers seems feasible. [7] However, reactions involving 3,3-diarylacrylates (especially free acids) proved to be challenging, as only moderate enantioselectivities were obtained, in most cases under high pressure (100 bar). Herein, we present the results of the development of an efficient asymmetric hydrogenation of b,b-diarylacrylic acids in the presence of a Rh complex based on the heterocombination of a chiral monodentate secondary phosphine oxide (SPO) preligand and an achiral monodentate phosphine ligand as the catalyst to afford a wide variety of the corresponding b,b-diarylpropionic acids with biological importance in excellent optical purities.The most challenging issue associated with the control of stereochemistry in the asymmetric hydrogenation of b,bdiarylacrylic acids is the differentiation of a stereogenic center with two sterically similar aryl groups at the b-position of acrylic acids. [3][4][5][6][7][8] Very recently, we disclosed that Rh I catalysts generated in situ by interaction with SPO preligands demonstrated excellent performance in the asymmetric hydrogenation of a-substituted ethenylphosphonic acids.[9] The salient features of SPO ligands, including ready accessibility, good air and moisture stability, and the potentially H-bonding OH group in the ligand, [9,10] prompted us to explore the catalytic potential of Rh I /SPO systems in the asymmetric hydrogenation of challenging b,b-diarylacrylic acid substrates. As shown in Table 1, chiral monodentate SPO preligands L1-L7 were evaluated in the rhodium-catalyzed asymmetric hydrogenation of (E)-3-phenyl-3-(p-tolyl) acrylic acid ((E)-1 a). However, an initial screening of ...